P3‐585: COGNITIVE RESERVE MODULATES THE ASSOCIATION OF CEREBRAL AMYLOID PATHOLOGY WITH COGNITIVE PERFORMANCE IN PERSONS WITH ALZHEIMER'S DISEASE DEMENTIA Article Swipe
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1016/j.jalz.2018.06.1951
The relationship between amyloid-ß deposition and the subsequent clinical expression of Alzheimer's disease (AD)-type dementia is found to be moderated by cognitive reserve. We here aim to investigate whether the protective effect of cognitive reserve on amyloid-related cognitive decline sustains in the dementia phase, and whether this potential moderating effect is influenced by age, apolipoprotein E (APOE)-ε4 carrier status and gender. We studied 1648 subjects with a clinical diagnosis of dementia of AD-type included in the Amyloid Biomarker Study. Cognitive performance was assessed by the Mini-Mental State Examination (MMSE). Amyloid-ß deposition was measured with positron emission tomography or cerebrospinal-fluid biomarkers and dichotomized as normal or abnormal according to study-specific cut-offs. Years of formal education as a proxy of cognitive reserve were divided based on tertiles in low (15 years). Generalized-estimating-equations were used to estimate the moderating effect of educational level on the cross-sectional relationship between amyloid status and low MMSE score (<24). We also examined associations with age, APOE-ε4 carrier status and gender. Average age was 69.6 years, 50.3% were female, 59.4% had a low MMSE score and 1366 (82.9%) individuals were amyloid positive. The relation between amyloid positivity and cognitive performance differed according to education group (P = .049). The effect of education on cognitive performance was different in amyloid positive and amyloid negative patients (Figure 1). In amyloid positive participants, individuals with a high educational level less often had a low MMSE score compared to individuals with intermediate or low education (mean difference 13-18%, P < .001). In amyloid negative participants, individuals with both a high and intermediate level of education performed better than those with a low education (mean difference 16-18%, P <.01). Age, APOE-ε4 carrier status and gender had moderating effects on this association. Frequencies of low Mini-Mental State Examination (MMSE) scores in AD individuals. Model with terms for age, amyloid status, and interactions between amyloid status and education groups (P = .049). Low MMSE score was defined as <24. High cognitive reserve protects against cognitive decline among individuals with dementia, regardless of amyloid status. Intermediate cognitive reserve may protect against decline in amyloid-negative persons with dementia. These results could help improve our understanding of the disease and implicate the potential of cognitive reserve to delay cognitive impairment.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.jalz.2018.06.1951
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2895795514
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2895795514Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.jalz.2018.06.1951Digital Object Identifier
- Title
-
P3‐585: COGNITIVE RESERVE MODULATES THE ASSOCIATION OF CEREBRAL AMYLOID PATHOLOGY WITH COGNITIVE PERFORMANCE IN PERSONS WITH ALZHEIMER'S DISEASE DEMENTIAWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-07-01Full publication date if available
- Authors
-
Olin Janssen, Willemijn J. Jansen, Rik Ossenkoppele, Nancy N. Maserejian, Frans R.J. Verhey, Stephanie J. B. Vos, Pieter Jelle VisserList of authors in order
- Landing page
-
https://doi.org/10.1016/j.jalz.2018.06.1951Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951Direct OA link when available
- Concepts
-
Dementia, Cognitive reserve, Apolipoprotein E, Cognition, Amyloid (mycology), Internal medicine, Effects of sleep deprivation on cognitive performance, Psychology, Medicine, Alzheimer's disease, Biomarker, Disease, Pittsburgh compound B, Mini–Mental State Examination, Cognitive decline, Oncology, Clinical psychology, Pathology, Psychiatry, Biology, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2895795514 |
|---|---|
| doi | https://doi.org/10.1016/j.jalz.2018.06.1951 |
| ids.doi | https://doi.org/10.1016/j.jalz.2018.06.1951 |
| ids.mag | 2895795514 |
| ids.openalex | https://openalex.org/W2895795514 |
| fwci | 0.0 |
| type | article |
| title | P3‐585: COGNITIVE RESERVE MODULATES THE ASSOCIATION OF CEREBRAL AMYLOID PATHOLOGY WITH COGNITIVE PERFORMANCE IN PERSONS WITH ALZHEIMER'S DISEASE DEMENTIA |
| biblio.issue | 7S_Part_25 |
| biblio.volume | 14 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10009 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.7694000005722046 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2738 |
| topics[0].subfield.display_name | Psychiatry and Mental health |
| topics[0].display_name | Dementia and Cognitive Impairment Research |
| is_xpac | False |
| apc_list.value | 4000 |
| apc_list.currency | USD |
| apc_list.value_usd | 4000 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779483572 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7899563312530518 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q83030 |
| concepts[0].display_name | Dementia |
| concepts[1].id | https://openalex.org/C67739388 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7116325497627258 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q579471 |
| concepts[1].display_name | Cognitive reserve |
| concepts[2].id | https://openalex.org/C57089818 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6035243272781372 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q424728 |
| concepts[2].display_name | Apolipoprotein E |
| concepts[3].id | https://openalex.org/C169900460 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5697441697120667 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2200417 |
| concepts[3].display_name | Cognition |
| concepts[4].id | https://openalex.org/C2777633098 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5408658385276794 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2736051 |
| concepts[4].display_name | Amyloid (mycology) |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.516028642654419 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C185711340 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5041803121566772 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q5347381 |
| concepts[6].display_name | Effects of sleep deprivation on cognitive performance |
| concepts[7].id | https://openalex.org/C15744967 |
| concepts[7].level | 0 |
| concepts[7].score | 0.4632742404937744 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[7].display_name | Psychology |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.46103692054748535 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C502032728 |
| concepts[9].level | 3 |
| concepts[9].score | 0.44512367248535156 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11081 |
| concepts[9].display_name | Alzheimer's disease |
| concepts[10].id | https://openalex.org/C2781197716 |
| concepts[10].level | 2 |
| concepts[10].score | 0.43004217743873596 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q864574 |
| concepts[10].display_name | Biomarker |
| concepts[11].id | https://openalex.org/C2779134260 |
| concepts[11].level | 2 |
| concepts[11].score | 0.42101171612739563 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[11].display_name | Disease |
| concepts[12].id | https://openalex.org/C2781073650 |
| concepts[12].level | 4 |
| concepts[12].score | 0.4189894199371338 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q4047010 |
| concepts[12].display_name | Pittsburgh compound B |
| concepts[13].id | https://openalex.org/C2779077818 |
| concepts[13].level | 4 |
| concepts[13].score | 0.41856926679611206 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q913257 |
| concepts[13].display_name | Mini–Mental State Examination |
| concepts[14].id | https://openalex.org/C2984863031 |
| concepts[14].level | 4 |
| concepts[14].score | 0.4182448387145996 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q83030 |
| concepts[14].display_name | Cognitive decline |
| concepts[15].id | https://openalex.org/C143998085 |
| concepts[15].level | 1 |
| concepts[15].score | 0.38283994793891907 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[15].display_name | Oncology |
| concepts[16].id | https://openalex.org/C70410870 |
| concepts[16].level | 1 |
| concepts[16].score | 0.3605290651321411 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q199906 |
| concepts[16].display_name | Clinical psychology |
| concepts[17].id | https://openalex.org/C142724271 |
| concepts[17].level | 1 |
| concepts[17].score | 0.2846927344799042 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[17].display_name | Pathology |
| concepts[18].id | https://openalex.org/C118552586 |
| concepts[18].level | 1 |
| concepts[18].score | 0.26746195554733276 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[18].display_name | Psychiatry |
| concepts[19].id | https://openalex.org/C86803240 |
| concepts[19].level | 0 |
| concepts[19].score | 0.07335242629051208 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[19].display_name | Biology |
| concepts[20].id | https://openalex.org/C55493867 |
| concepts[20].level | 1 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[20].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/dementia |
| keywords[0].score | 0.7899563312530518 |
| keywords[0].display_name | Dementia |
| keywords[1].id | https://openalex.org/keywords/cognitive-reserve |
| keywords[1].score | 0.7116325497627258 |
| keywords[1].display_name | Cognitive reserve |
| keywords[2].id | https://openalex.org/keywords/apolipoprotein-e |
| keywords[2].score | 0.6035243272781372 |
| keywords[2].display_name | Apolipoprotein E |
| keywords[3].id | https://openalex.org/keywords/cognition |
| keywords[3].score | 0.5697441697120667 |
| keywords[3].display_name | Cognition |
| keywords[4].id | https://openalex.org/keywords/amyloid |
| keywords[4].score | 0.5408658385276794 |
| keywords[4].display_name | Amyloid (mycology) |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.516028642654419 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/effects-of-sleep-deprivation-on-cognitive-performance |
| keywords[6].score | 0.5041803121566772 |
| keywords[6].display_name | Effects of sleep deprivation on cognitive performance |
| keywords[7].id | https://openalex.org/keywords/psychology |
| keywords[7].score | 0.4632742404937744 |
| keywords[7].display_name | Psychology |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.46103692054748535 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/alzheimers-disease |
| keywords[9].score | 0.44512367248535156 |
| keywords[9].display_name | Alzheimer's disease |
| keywords[10].id | https://openalex.org/keywords/biomarker |
| keywords[10].score | 0.43004217743873596 |
| keywords[10].display_name | Biomarker |
| keywords[11].id | https://openalex.org/keywords/disease |
| keywords[11].score | 0.42101171612739563 |
| keywords[11].display_name | Disease |
| keywords[12].id | https://openalex.org/keywords/pittsburgh-compound-b |
| keywords[12].score | 0.4189894199371338 |
| keywords[12].display_name | Pittsburgh compound B |
| keywords[13].id | https://openalex.org/keywords/mini–mental-state-examination |
| keywords[13].score | 0.41856926679611206 |
| keywords[13].display_name | Mini–Mental State Examination |
| keywords[14].id | https://openalex.org/keywords/cognitive-decline |
| keywords[14].score | 0.4182448387145996 |
| keywords[14].display_name | Cognitive decline |
| keywords[15].id | https://openalex.org/keywords/oncology |
| keywords[15].score | 0.38283994793891907 |
| keywords[15].display_name | Oncology |
| keywords[16].id | https://openalex.org/keywords/clinical-psychology |
| keywords[16].score | 0.3605290651321411 |
| keywords[16].display_name | Clinical psychology |
| keywords[17].id | https://openalex.org/keywords/pathology |
| keywords[17].score | 0.2846927344799042 |
| keywords[17].display_name | Pathology |
| keywords[18].id | https://openalex.org/keywords/psychiatry |
| keywords[18].score | 0.26746195554733276 |
| keywords[18].display_name | Psychiatry |
| keywords[19].id | https://openalex.org/keywords/biology |
| keywords[19].score | 0.07335242629051208 |
| keywords[19].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1016/j.jalz.2018.06.1951 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S108427512 |
| locations[0].source.issn | 1552-5260, 1552-5279 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1552-5260 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Alzheimer s & Dementia |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Alzheimer's & Dementia |
| locations[0].landing_page_url | https://doi.org/10.1016/j.jalz.2018.06.1951 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5008256521 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8341-0958 |
| authorships[0].author.display_name | Olin Janssen |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[0].affiliations[0].raw_affiliation_string | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[0].institutions[0].id | https://openalex.org/I34352273 |
| authorships[0].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | Maastricht University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Olin Janssen |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[1].author.id | https://openalex.org/A5079973736 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9081-1496 |
| authorships[1].author.display_name | Willemijn J. Jansen |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[1].affiliations[0].raw_affiliation_string | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[1].institutions[0].id | https://openalex.org/I34352273 |
| authorships[1].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | Maastricht University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Willemijn J. Jansen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[2].author.id | https://openalex.org/A5024110469 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1584-7477 |
| authorships[2].author.display_name | Rik Ossenkoppele |
| authorships[2].countries | NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210108594 |
| authorships[2].affiliations[0].raw_affiliation_string | Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands |
| authorships[2].institutions[0].id | https://openalex.org/I4210108594 |
| authorships[2].institutions[0].ror | https://ror.org/01x2d9f70 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210108594 |
| authorships[2].institutions[0].country_code | NL |
| authorships[2].institutions[0].display_name | Amsterdam Neuroscience |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Rik Ossenkoppele |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands |
| authorships[3].author.id | https://openalex.org/A5039119591 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Nancy N. Maserejian |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[3].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[3].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Biogen (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nancy Nairi Maserejian |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[4].author.id | https://openalex.org/A5054596281 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8307-8406 |
| authorships[4].author.display_name | Frans R.J. Verhey |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[4].affiliations[0].raw_affiliation_string | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[4].institutions[0].id | https://openalex.org/I34352273 |
| authorships[4].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | Maastricht University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Frans R.J. Verhey |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[5].author.id | https://openalex.org/A5068903009 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Stephanie J. B. Vos |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[5].affiliations[0].raw_affiliation_string | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[5].institutions[0].id | https://openalex.org/I34352273 |
| authorships[5].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | Maastricht University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Stephanie J.B. Vos |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[6].author.id | https://openalex.org/A5029875703 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8008-9727 |
| authorships[6].author.display_name | Pieter Jelle Visser |
| authorships[6].countries | NL |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210108594 |
| authorships[6].affiliations[0].raw_affiliation_string | Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I34352273 |
| authorships[6].affiliations[1].raw_affiliation_string | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
| authorships[6].institutions[0].id | https://openalex.org/I4210108594 |
| authorships[6].institutions[0].ror | https://ror.org/01x2d9f70 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210108594 |
| authorships[6].institutions[0].country_code | NL |
| authorships[6].institutions[0].display_name | Amsterdam Neuroscience |
| authorships[6].institutions[1].id | https://openalex.org/I34352273 |
| authorships[6].institutions[1].ror | https://ror.org/02jz4aj89 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I34352273 |
| authorships[6].institutions[1].country_code | NL |
| authorships[6].institutions[1].display_name | Maastricht University |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Pieter Jelle Visser |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | P3‐585: COGNITIVE RESERVE MODULATES THE ASSOCIATION OF CEREBRAL AMYLOID PATHOLOGY WITH COGNITIVE PERFORMANCE IN PERSONS WITH ALZHEIMER'S DISEASE DEMENTIA |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10009 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.7694000005722046 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2738 |
| primary_topic.subfield.display_name | Psychiatry and Mental health |
| primary_topic.display_name | Dementia and Cognitive Impairment Research |
| related_works | https://openalex.org/W1994839012, https://openalex.org/W2148161188, https://openalex.org/W2538174166, https://openalex.org/W2548448435, https://openalex.org/W2621987768, https://openalex.org/W2725587666, https://openalex.org/W4378228432, https://openalex.org/W2221276418, https://openalex.org/W3047023166, https://openalex.org/W2000740249 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.jalz.2018.06.1951 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S108427512 |
| best_oa_location.source.issn | 1552-5260, 1552-5279 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1552-5260 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Alzheimer s & Dementia |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Alzheimer's & Dementia |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.jalz.2018.06.1951 |
| primary_location.id | doi:10.1016/j.jalz.2018.06.1951 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S108427512 |
| primary_location.source.issn | 1552-5260, 1552-5279 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1552-5260 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Alzheimer s & Dementia |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.06.1951 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Alzheimer's & Dementia |
| primary_location.landing_page_url | https://doi.org/10.1016/j.jalz.2018.06.1951 |
| publication_date | 2018-07-01 |
| publication_year | 2018 |
| referenced_works_count | 0 |
| abstract_inverted_index.< | 255 |
| abstract_inverted_index.= | 206, 323 |
| abstract_inverted_index.E | 55 |
| abstract_inverted_index.P | 254, 282 |
| abstract_inverted_index.a | 66, 115, 181, 232, 239, 264, 276 |
| abstract_inverted_index.(P | 205, 322 |
| abstract_inverted_index.AD | 305 |
| abstract_inverted_index.In | 226, 257 |
| abstract_inverted_index.We | 23, 61, 160 |
| abstract_inverted_index.as | 102, 114, 330 |
| abstract_inverted_index.be | 18 |
| abstract_inverted_index.by | 20, 52, 83 |
| abstract_inverted_index.in | 40, 74, 125, 217, 304, 354 |
| abstract_inverted_index.is | 15, 50 |
| abstract_inverted_index.of | 10, 32, 69, 71, 111, 117, 145, 210, 269, 297, 344, 366, 373 |
| abstract_inverted_index.on | 35, 123, 148, 212, 293 |
| abstract_inverted_index.or | 97, 104, 248 |
| abstract_inverted_index.to | 17, 26, 107, 140, 202, 244, 376 |
| abstract_inverted_index.1). | 225 |
| abstract_inverted_index.Low | 325 |
| abstract_inverted_index.The | 0, 192, 208 |
| abstract_inverted_index.age | 172 |
| abstract_inverted_index.aim | 25 |
| abstract_inverted_index.and | 5, 44, 59, 100, 132, 155, 169, 185, 197, 220, 266, 288, 314, 319, 369 |
| abstract_inverted_index.for | 310 |
| abstract_inverted_index.had | 180, 238, 290 |
| abstract_inverted_index.low | 126, 156, 182, 240, 249, 277, 298 |
| abstract_inverted_index.may | 350 |
| abstract_inverted_index.our | 364 |
| abstract_inverted_index.the | 6, 29, 41, 75, 84, 142, 149, 367, 371 |
| abstract_inverted_index.was | 81, 91, 173, 215, 328 |
| abstract_inverted_index.(<12 | 127 |
| abstract_inverted_index.(>15 | 135 |
| abstract_inverted_index.1366 | 186 |
| abstract_inverted_index.1648 | 63 |
| abstract_inverted_index.69.6 | 174 |
| abstract_inverted_index.<24. | 331 |
| abstract_inverted_index.Age, | 284 |
| abstract_inverted_index.High | 332 |
| abstract_inverted_index.MMSE | 157, 183, 241, 326 |
| abstract_inverted_index.age, | 53, 165, 311 |
| abstract_inverted_index.also | 161 |
| abstract_inverted_index.both | 263 |
| abstract_inverted_index.help | 362 |
| abstract_inverted_index.here | 24 |
| abstract_inverted_index.high | 133, 233, 265 |
| abstract_inverted_index.less | 236 |
| abstract_inverted_index.than | 273 |
| abstract_inverted_index.this | 46, 294 |
| abstract_inverted_index.used | 139 |
| abstract_inverted_index.were | 120, 138, 177, 189 |
| abstract_inverted_index.with | 65, 93, 164, 231, 246, 262, 275, 308, 341, 357 |
| abstract_inverted_index.(mean | 251, 279 |
| abstract_inverted_index.50.3% | 176 |
| abstract_inverted_index.59.4% | 179 |
| abstract_inverted_index.Model | 307 |
| abstract_inverted_index.State | 86, 300 |
| abstract_inverted_index.These | 359 |
| abstract_inverted_index.Years | 110 |
| abstract_inverted_index.among | 339 |
| abstract_inverted_index.based | 122 |
| abstract_inverted_index.could | 361 |
| abstract_inverted_index.delay | 377 |
| abstract_inverted_index.found | 16 |
| abstract_inverted_index.group | 204 |
| abstract_inverted_index.level | 147, 235, 268 |
| abstract_inverted_index.often | 237 |
| abstract_inverted_index.proxy | 116 |
| abstract_inverted_index.score | 158, 184, 242, 327 |
| abstract_inverted_index.terms | 309 |
| abstract_inverted_index.those | 274 |
| abstract_inverted_index.(12-15 | 130 |
| abstract_inverted_index.(<24). | 159 |
| abstract_inverted_index.(MMSE) | 302 |
| abstract_inverted_index..001). | 256 |
| abstract_inverted_index..049). | 207, 324 |
| abstract_inverted_index.<.01). | 283 |
| abstract_inverted_index.Study. | 78 |
| abstract_inverted_index.better | 272 |
| abstract_inverted_index.effect | 31, 49, 144, 209 |
| abstract_inverted_index.formal | 112 |
| abstract_inverted_index.gender | 289 |
| abstract_inverted_index.groups | 321 |
| abstract_inverted_index.normal | 103 |
| abstract_inverted_index.phase, | 43 |
| abstract_inverted_index.scores | 303 |
| abstract_inverted_index.status | 58, 154, 168, 287, 318 |
| abstract_inverted_index.years, | 175 |
| abstract_inverted_index.(82.9%) | 187 |
| abstract_inverted_index.(Figure | 224 |
| abstract_inverted_index.(MMSE). | 88 |
| abstract_inverted_index.13-18%, | 253 |
| abstract_inverted_index.16-18%, | 281 |
| abstract_inverted_index.AD-type | 72 |
| abstract_inverted_index.Amyloid | 76 |
| abstract_inverted_index.Average | 171 |
| abstract_inverted_index.against | 336, 352 |
| abstract_inverted_index.amyloid | 153, 190, 195, 218, 221, 227, 258, 312, 317, 345 |
| abstract_inverted_index.between | 2, 152, 194, 316 |
| abstract_inverted_index.carrier | 57, 167, 286 |
| abstract_inverted_index.decline | 38, 338, 353 |
| abstract_inverted_index.defined | 329 |
| abstract_inverted_index.disease | 12, 368 |
| abstract_inverted_index.divided | 121 |
| abstract_inverted_index.effects | 292 |
| abstract_inverted_index.female, | 178 |
| abstract_inverted_index.gender. | 60, 170 |
| abstract_inverted_index.improve | 363 |
| abstract_inverted_index.persons | 356 |
| abstract_inverted_index.protect | 351 |
| abstract_inverted_index.reserve | 34, 119, 334, 349, 375 |
| abstract_inverted_index.results | 360 |
| abstract_inverted_index.status, | 313 |
| abstract_inverted_index.status. | 346 |
| abstract_inverted_index.studied | 62 |
| abstract_inverted_index.whether | 28, 45 |
| abstract_inverted_index.years), | 128, 131 |
| abstract_inverted_index.years). | 136 |
| abstract_inverted_index.APOE-ε4 | 166, 285 |
| abstract_inverted_index.abnormal | 105 |
| abstract_inverted_index.assessed | 82 |
| abstract_inverted_index.clinical | 8, 67 |
| abstract_inverted_index.compared | 243 |
| abstract_inverted_index.dementia | 14, 42, 70 |
| abstract_inverted_index.differed | 200 |
| abstract_inverted_index.emission | 95 |
| abstract_inverted_index.estimate | 141 |
| abstract_inverted_index.examined | 162 |
| abstract_inverted_index.included | 73 |
| abstract_inverted_index.measured | 92 |
| abstract_inverted_index.negative | 222, 259 |
| abstract_inverted_index.patients | 223 |
| abstract_inverted_index.positive | 219, 228 |
| abstract_inverted_index.positron | 94 |
| abstract_inverted_index.protects | 335 |
| abstract_inverted_index.relation | 193 |
| abstract_inverted_index.reserve. | 22 |
| abstract_inverted_index.subjects | 64 |
| abstract_inverted_index.sustains | 39 |
| abstract_inverted_index.tertiles | 124 |
| abstract_inverted_index.(AD)-type | 13 |
| abstract_inverted_index.Biomarker | 77 |
| abstract_inverted_index.Cognitive | 79 |
| abstract_inverted_index.according | 106, 201 |
| abstract_inverted_index.cognitive | 21, 33, 37, 118, 198, 213, 333, 337, 348, 374, 378 |
| abstract_inverted_index.cut-offs. | 109 |
| abstract_inverted_index.dementia, | 342 |
| abstract_inverted_index.dementia. | 358 |
| abstract_inverted_index.diagnosis | 68 |
| abstract_inverted_index.different | 216 |
| abstract_inverted_index.education | 113, 134, 203, 211, 250, 270, 278, 320 |
| abstract_inverted_index.implicate | 370 |
| abstract_inverted_index.moderated | 19 |
| abstract_inverted_index.performed | 271 |
| abstract_inverted_index.positive. | 191 |
| abstract_inverted_index.potential | 47, 372 |
| abstract_inverted_index.(APOE)-ε4 | 56 |
| abstract_inverted_index.Amyloid-ß | 89 |
| abstract_inverted_index.amyloid-ß | 3 |
| abstract_inverted_index.biomarkers | 99 |
| abstract_inverted_index.deposition | 4, 90 |
| abstract_inverted_index.difference | 252, 280 |
| abstract_inverted_index.expression | 9 |
| abstract_inverted_index.influenced | 51 |
| abstract_inverted_index.moderating | 48, 143, 291 |
| abstract_inverted_index.positivity | 196 |
| abstract_inverted_index.protective | 30 |
| abstract_inverted_index.regardless | 343 |
| abstract_inverted_index.subsequent | 7 |
| abstract_inverted_index.tomography | 96 |
| abstract_inverted_index.Alzheimer's | 11 |
| abstract_inverted_index.Examination | 87, 301 |
| abstract_inverted_index.Frequencies | 296 |
| abstract_inverted_index.Mini-Mental | 85, 299 |
| abstract_inverted_index.educational | 146, 234 |
| abstract_inverted_index.impairment. | 379 |
| abstract_inverted_index.individuals | 188, 230, 245, 261, 340 |
| abstract_inverted_index.investigate | 27 |
| abstract_inverted_index.performance | 80, 199, 214 |
| abstract_inverted_index.Intermediate | 347 |
| abstract_inverted_index.association. | 295 |
| abstract_inverted_index.associations | 163 |
| abstract_inverted_index.dichotomized | 101 |
| abstract_inverted_index.individuals. | 306 |
| abstract_inverted_index.interactions | 315 |
| abstract_inverted_index.intermediate | 129, 247, 267 |
| abstract_inverted_index.relationship | 1, 151 |
| abstract_inverted_index.participants, | 229, 260 |
| abstract_inverted_index.understanding | 365 |
| abstract_inverted_index.apolipoprotein | 54 |
| abstract_inverted_index.study-specific | 108 |
| abstract_inverted_index.amyloid-related | 36 |
| abstract_inverted_index.cross-sectional | 150 |
| abstract_inverted_index.amyloid-negative | 355 |
| abstract_inverted_index.cerebrospinal-fluid | 98 |
| abstract_inverted_index.Generalized-estimating-equations | 137 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5008256521 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I34352273 |
| citation_normalized_percentile.value | 0.15082228 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |